109 related articles for article (PubMed ID: 26216728)
1. Setting the bar: compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center.
Liang MI; ElNaggar AC; Nekkanti S; O'Malley DM; Hade EM; Copeland LJ; Fowler JM; Salani R; Backes FJ; Cohn DE
Gynecol Oncol; 2015 Sep; 138(3):689-93. PubMed ID: 26216728
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Society of Gynecologic Oncologists (SGO) ovarian cancer quality surgical measures.
Gogoi RP; Urban R; Sun H; Goff B
Gynecol Oncol; 2012 Aug; 126(2):217-9. PubMed ID: 22561039
[TBL] [Abstract][Full Text] [Related]
3. Re-operation outcome in patients referred to a gynecologic oncology center with presumed ovarian cancer FIGO I-IIIA after sub-standard initial surgery.
Grabowski JP; Harter P; Buhrmann C; Lorenz D; Hils R; Kommoss S; Traut A; du Bois A
Surg Oncol; 2012 Mar; 21(1):31-5. PubMed ID: 20875732
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study.
Ansquer Y; Leblanc E; Clough K; Morice P; Dauplat J; Mathevet P; Lhommé C; Scherer C; Tigaud JD; Benchaib M; Fourme E; Castaigne D; Querleu D; Dargent D
Cancer; 2001 Jun; 91(12):2329-34. PubMed ID: 11413522
[TBL] [Abstract][Full Text] [Related]
5. The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Results from North Jutland, Denmark.
Soegaard Andersen E; Knudsen A; Svarrer T; Lund B; Nielsen K; Grove A; Tetsche M
Gynecol Oncol; 2005 Dec; 99(3):552-6. PubMed ID: 16150480
[TBL] [Abstract][Full Text] [Related]
6. Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome.
Sijmons EA; van Lankveld MA; Witteveen PO; Peeters PH; Koot VC; van Leeuwen JS
Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):203-8. PubMed ID: 16707204
[TBL] [Abstract][Full Text] [Related]
7. The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer.
Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Aghajanian C; Barakat RR; Chi DS
Gynecol Oncol; 2008 Feb; 108(2):276-81. PubMed ID: 18063020
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
9. What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?
Eisenkop SM; Spirtos NM
Gynecol Oncol; 2001 Sep; 82(3):489-97. PubMed ID: 11520145
[TBL] [Abstract][Full Text] [Related]
10. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
11. Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer.
Gray HJ; Shah CA; Swensen RE; Tamimi HK; Goff BA
Gynecol Oncol; 2010 Mar; 116(3):340-4. PubMed ID: 19922987
[TBL] [Abstract][Full Text] [Related]
12. Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center.
ElNaggar AC; Hade EM; O'Malley DM; Liang MI; Copeland LJ; Fowler JM; Salani R; Backes FJ; Cohn DE
Gynecol Oncol; 2018 Dec; 151(3):501-505. PubMed ID: 30282591
[TBL] [Abstract][Full Text] [Related]
13. Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: an early glimpse into a challenging initiative.
Cohn DE; Leitao M; Levenback C; Berkowitz R; Roman L; Lucci J; Kim S; Lancaster J; Odunsi K; Wakabayashi M; Goff BA
Gynecol Oncol; 2013 Sep; 130(3):403-6. PubMed ID: 23718934
[TBL] [Abstract][Full Text] [Related]
14. A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model.
Aletti GD; Santillan A; Eisenhauer EL; Hu J; Aletti G; Podratz KC; Bristow RE; Chi DS; Cliby WA
Gynecol Oncol; 2007 Oct; 107(1):99-106. PubMed ID: 17602726
[TBL] [Abstract][Full Text] [Related]
15. The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: survey results from members of the Society of Gynecologic Oncologists.
Dewdney SB; Rimel BJ; Reinhart AJ; Kizer NT; Brooks RA; Massad LS; Zighelboim I
Gynecol Oncol; 2010 Oct; 119(1):18-21. PubMed ID: 20673970
[TBL] [Abstract][Full Text] [Related]
16. Variations in compliance to quality indicators by age for 41,871 breast cancer patients across Europe: a European Society of Breast Cancer Specialists database analysis.
Kiderlen M; Ponti A; Tomatis M; Boelens PG; Bastiaannet E; Wilson R; van de Velde CJ; Audisio RA;
Eur J Cancer; 2015 Jul; 51(10):1221-30. PubMed ID: 25892645
[TBL] [Abstract][Full Text] [Related]
17. Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy.
Estes JM; Leath CA; Straughn JM; Rocconi RP; Kirby TO; Huh WK; Barnes MN
J Am Coll Surg; 2006 Oct; 203(4):527-32. PubMed ID: 17000397
[TBL] [Abstract][Full Text] [Related]
18. Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer.
Barlin JN; Dao F; Bou Zgheib N; Ferguson SE; Sabbatini PJ; Hensley ML; Bell-McGuinn KM; Konner J; Tew WP; Aghajanian C; Chi DS
Gynecol Oncol; 2012 Jun; 125(3):621-4. PubMed ID: 22446622
[TBL] [Abstract][Full Text] [Related]
19. Low rate of intraperitoneal port placement in ovarian cancer patients, a population-based assessment.
Buckingham L; Koenig A; Ko EM; Brensinger CM; Latif N; Hummel C; Zhang X; Morgan MA; Burger RA; Giuntoli Ii RL
Int J Gynecol Cancer; 2019 Sep; 29(7):1177-1181. PubMed ID: 31302627
[TBL] [Abstract][Full Text] [Related]
20. A criterion-based audit of the technical quality of external beam radiotherapy for prostate cancer.
Brundage M; Danielson B; Pearcey R; Bass B; Pickles T; Bahary JP; Peng Y; Wallace D; Mackillop W
Radiother Oncol; 2013 Jun; 107(3):339-45. PubMed ID: 23830469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
